Microsoft CEO Satya Nadella's debut book will hit stores next year with the writer saying it is neither a 'how-to-succeed' book nor a memoir but about change. 'Hit Refresh' follows three storylines: Nadella's personal journey of transformation, the change that is taking place today inside his storied technology company, and one that is coming in all of our lives as intelligent machines become more ambient and more ubiquitous throughout society, publishers Harper Business said. "Harper Business, an imprint of HarperCollins Publishers, has acquired World English rights to Microsoft CEO Satya Nadella's first book, 'Hit Refresh'. Hollis Heimbouch, vice-president and publisher, Harper Business, negotiated the deal with James Levine of Levine Greenberg Rostan Literary Agency. This book is about change," said Nadella. "It is not a 'how to succeed' book, nor is it a memoir - it's premature for that. Ultimately, I am writing for Microsoft team members, customers, and partners in hopes that these stories of transformation will be useful to them as they navigate their own path." The author's proceeds from the book will be donated to Microsoft Philanthropies to benefit nonprofits, specifically those working on public cloud for public good projects.
Thursday, 30 June 2016
Home »
» Microsoft CEO Satya Nadella's debut book to come out in 2017 -:- Equity Research
Microsoft CEO Satya Nadella's debut book to come out in 2017 -:- Equity Research
03:50
Related Posts:
Mangalore Chem up 17% after shareholders reject Zuari Agro deal -:- Equity Research MCFL, which became a subsidiary of Zuari Fertilisers and Chemicals in 2015, proposed to enter into certain transactions, in its ordinary course of business, relating to purchase / sale of goods, availing / rendering of ser… Read More
KCP Sugar may move to Rs 46-:- Equity Research G Chokkalingam, Founder & MD at Equinomics Research & Advisory told CNBC-TV18, "In KCP Sugar we successfully made money and it went to Rs 46 recently. Now again it has corrected back to around Rs 33-34 level.… Read More
Lupin off day's low after USFDA approval for anti-alzheimer drug-:- Equity Research Pharma major Lupin shares halved losses in afternoon trade Thursday on approval from the US health regulator for for anti-alzheimer drug. The stock reduced its losses to 2 percent from 4 percent intraday. "... has received… Read More
Anti-dumping duty likely on certain Chinese steel products-:- Equity Research The commerce ministry has recommended imposition of anti-dumping duty on imports of steel wire rods from China to protect the interest of domestic players from cheap in-bound shipments. In its preliminary findings, the dir… Read More
Look at ICICI Prudential at around Rs 280-285-:- Equity Research G Chokkalingam, Founder & MD at Equinomics Research & Advisory told CNBC-TV18, "We advised our clients not to apply to ICICI Prudential Life Insurance Company because we have found that it is quite stretched in ter… Read More
0 comments:
Post a Comment